Therapeutic Effect of 0.03% Tacrolimus Ointment for Ocular Graft versus Host Disease and Vernal Keratoconjunctivitis
Eun Hye Ryu, Joung Mok Kim, Pradnya M Laddha, Eui-Sang Chung, Tae-Young Chung
Korean J Ophthalmol. 2012;26(4):241-247.   Published online 2012 Jul 24     DOI: https://doi.org/10.3341/kjo.2012.26.4.241
Citations to this article as recorded by Crossref logo
Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop
Xurxo García-Otero, Victoria Díaz-Tomé, Rubén Varela-Fernández, Manuel Martín-Pastor, Miguel González-Barcia, José Blanco-Méndez, Cristina Mondelo-García, Maria A. Bermudez, Francisco Gonzalez, Pablo Aguiar, Anxo Fernández-Ferreiro, Francisco J. Otero-Esp
Pharmaceutics.2021; 13(2): 149.     CrossRef
Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patients
Kyungmin Koh, Ikhyun Jun, Tae-im Kim, Eung Kweon Kim, Kyoung Yul Seo
BMC Ophthalmology.2021;[Epub]     CrossRef
Safety and efficacy of tacrolimus-coated silicone plates as an alternative to mitomycin C in a rabbit model of conjunctival fibrosis
Sam Young Yoon, Eun-Soon Kim, Gill Sang Han, Leejee H. Suh, Hyun Suk Jung, Hungwon Tchah, Jae Yong Kim, Shree K. Kurup
PLOS ONE.2019; 14(7): e0219194.     CrossRef
Graft versus host disease: a pediatric perspective
Simon SM Fung, Uri Elbaz, Kamiar Mireskandari, Asim Ali
Expert Review of Ophthalmology.2019; 14(2): 89.     CrossRef
Topical Tacrolimus as Adjuvant Therapy to Corticosteroids in Acute Endothelial Graft Rejection After Penetrating Keratoplasty: A Randomized Controlled Trial
Mohammad Nasser Hashemian, Golshan Latifi, Reza Ghaffari, Hamed Ghassemi, Mehran Zarei-Ghanavati, Seyed-Farzad Mohammadi, Mehdi Yasseri, Mohammad Reza Fallah Tafti, Zahra Fallah Tafti
Cornea.2018; 37(3): 307.     CrossRef
Formulation characteristics and in vitro release testing of cyclosporine ophthalmic ointments
Yixuan Dong, Haiou Qu, Naresh Pavurala, Jiang Wang, Vasanthakumar Sekar, Marilyn N. Martinez, Raafat Fahmy, Muhammad Ashraf, Celia N. Cruz, Xiaoming Xu
International Journal of Pharmaceutics.2018; 544(1): 254.     CrossRef
Current Approaches to Treatment of Ocular Graft-Versus-Host Disease
Cynthia I. Tung
International Ophthalmology Clinics.2017; 57(2): 65.     CrossRef
Comparative Evaluation of Tacrolimus Versus Interferon Alpha-2b Eye Drops in the Treatment of Vernal Keratoconjunctivitis: A Randomized, Double-Masked Study
Habibollah Zanjani, Mohammad Naim Aminifard, Abdolhossein Ghafourian, Mohsen Pourazizi, Alireza Maleki, Mohammed Arish, Mahnaz Shahrakipoor, Mohammad Reza Rohani, Mojtaba Abrishami, Ehsan Khafri Zare, Farhad Barzegar Jalali
Cornea.2017; 36(6): 675.     CrossRef
Long-term safety and efficacy of autologous platelet lysate drops for treatment of ocular GvHD
S Pezzotta, C Del Fante, L Scudeller, G C Rossi, C Perotti, P E Bianchi, E Antoniazzi
Bone Marrow Transplantation.2017; 52(1): 101.     CrossRef
Topical tacrolimus in anterior segment inflammatory disorders
Samir S. Shoughy
Eye and Vision.2017;[Epub]     CrossRef
A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease
Tulio B. Abud, Francisco Amparo, Ujwala S. Saboo, Antonio Di Zazzo, Thomas H. Dohlman, Joseph B. Ciolino, Pedram Hamrah, Reza Dana
Ophthalmology.2016; 123(7): 1449.     CrossRef
Mechanisms and management of dry eye in cataract surgery patients
Christine Sutu, Hideki Fukuoka, Natalie A. Afshari
Current Opinion in Ophthalmology.2016; 27(1): 24.     CrossRef
Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis
Samrat Chatterjee, Deepshikha Agrawal
Cornea.2016; 35(11): 1444.     CrossRef
Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation
Grace E. Boynton, Duna Raoof, Leslie M. Niziol, Munira Hussain, Shahzad I. Mian
Cornea.2015; 34(7): 725.     CrossRef
Therapeutic Strategies to Treat Dry Eye in an Aging Population
Nisreen S. Ezuddin, Karam A. Alawa, Anat Galor
Drugs & Aging.2015; 32(7): 505.     CrossRef
Challenges faced in clinical trials for chronic allergic conjunctivitis
Paul Gomes, Connie Slocum, Lisa M Smith, Mark B Abelson
Expert Review of Ophthalmology.2015; 10(5): 509.     CrossRef
Therapeutic Effects of 0.03% Tacrolimus Eye Drops for Chronic Ocular Graft-Versus-Host Disease
Soon Il Choi, So Hyang Chung
Journal of the Korean Ophthalmological Society.2015; 56(10): 1505.     CrossRef
Long-term Result of Maintenance Treatment With Tacrolimus Ointment in Chronic Ocular Graft-Versus-Host Disease
Ji Won Jung, Young Ji Lee, Sang Chul Yoon, Tae-im Kim, Eung Kweon Kim, Kyoung Yul Seo
American Journal of Ophthalmology.2015; 159(3): 519.     CrossRef
Advances in pharmacotherapy for allergic conjunctivitis
Mark B Abelson, Sirikishan Shetty, Michael Korchak, Salim I Butrus, Lisa M Smith
Expert Opinion on Pharmacotherapy.2015; 16(8): 1219.     CrossRef
Proniosome-derived niosomes for tacrolimus topical ocular delivery: In vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection
Qi Li, Zhanrong Li, Weidong Zeng, Shumin Ge, Haoyang Lu, Chuanbin Wu, Li Ge, Dan Liang, Yuehong Xu
European Journal of Pharmaceutical Sciences.2014; 62: 115.     CrossRef